Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Aliki Peletidi"'
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/013a5d43e794430fbf9b46f67e37b4aa
Autor:
Ilias Katsogiannis, Eirini Manara, Aliki Peletidi, Angeliki Bistaraki, Theodoros Constantinides, Christos Kontogiorgis
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 14, Iss , Pp 100445- (2024)
Introduction: Community pharmacists (CPs) are the most accessible healthcare professionals in primary care due to pharmacies' open-door policy and convenience, resulting in high patient and prescription volumes, and numerous free-of-charge consultati
Externí odkaz:
https://doaj.org/article/0f179cdc01b84cc6a886bcdec2085783
Autor:
Aliki Peletidi, Reem Kayyali
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 15, Iss 1 (2022)
Background Currently in Greece, no formal organisation offers post-academic education to pharmacists. To improve the clinical practice of pharmacists, there is a need for training that will educate them on how to approach and consult their patients.
Externí odkaz:
https://doaj.org/article/175a3f16ac8740d397ff22004e0aa983
Autor:
Periklis Charalampous, Aliki Peletidi
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 10, Iss 1, Pp 23-29 (2021)
Objective: The age-standardized prevalence of cardiovascular diseases (CVDs) among the Cypriot population in 2017 was estimated to be 5552 per 100,000. Therefore, the CVD prevention in Cyprus is of paramount importance. Pharmacists are one of the mos
Externí odkaz:
https://doaj.org/article/1b9273dcfaeb470d866c0d63a5908d2d
Autor:
Aliki Peletidi, Reem Kayyali
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 14, Iss 1 (2021)
Aims The primary aim of the programme was a minimum of a 5% weight reduction of the initial weight, while the secondary outcomes were a reduction in participants’ body mass index (BMI), waist circumference (WC), blood pressure (BP), AUDIT-C score a
Externí odkaz:
https://doaj.org/article/81755f6b0b924b5193eced1eddcba376
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 8, Iss 3, Pp 112-122 (2019)
Objective: In the United Kingdom (UK), cardiovascular disease (CVD) is the second main cause of death (27.4%) and the leading cause of death in Greece, accounting for 48% incidences. Pharmacists, the most accessible health-care professionals, can hav
Externí odkaz:
https://doaj.org/article/3a725f4f9672435594cd239ec5a0137d
Publikováno v:
Hellenic Journal of Cardiology, Vol 57, Iss 1, Pp 7-15 (2016)
Externí odkaz:
https://doaj.org/article/7c26ad87f5f44601bc9addeaa858a20d
Autor:
Aliki Peletidi, Reem Kayyali
Publikováno v:
Pharmacy, Vol 7, Iss 3, p 82 (2019)
Obesity constitutes one of the main modifiable risks of developing cardiovascular disease. In the UK, in 2016, 30% of the adult population were obese (30% of females and 29% of males). Community pharmacies are ideally situated to offer weight managem
Externí odkaz:
https://doaj.org/article/e4d4e9ac8fa643cfb741258f1e8d9f87
Publikováno v:
Pharmacy, Vol 5, Iss 2, p 33 (2017)
Purpose: Mobile health (mHealth) solutions have become an inevitable element of the healthcare landscape. The recommendation and use of mHealth is important, but it is often underutilised. This study was conducted in England. It aimed to determine th
Externí odkaz:
https://doaj.org/article/d3115688b7e5458d8fb9d319bf9a57b4
Autor:
Aliki Peletidi, Periklis Charalampous
Publikováno v:
Journal of Research in Pharmacy Practice, Vol 10, Iss 1, Pp 23-29 (2021)
Journal of Research in Pharmacy Practice
Journal of Research in Pharmacy Practice
Objective: The age-standardized prevalence of cardiovascular diseases (CVDs) among the Cypriot population in 2017 was estimated to be 5552 per 100,000. Therefore, the CVD prevention in Cyprus is of paramount importance. Pharmacists are one of the mos